MPD: Find data for mouse strain: CC006/TauUncJ

Sort/ Pick	Data set	Procedure / Protocol	Treatment	Phenotype Measure / Variable (click to view)	Panel	No. of Strains	Sex	Age	Sample Size (Avg)	Year
CSNA03:1	CSNA03	open field test	(none)	total distance traveled, 60 min test (OFT), founders [cm] dist_OFT_in 90001	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:2	CSNA03	open field test	(none)	total distance traveled, 60 min test (OFT), CC [cm] dist_OFT_cc 90002	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:4	CSNA03	open field test	(none)	distance traveled in perimeter and corners, 60 min test (OFT), founders [cm] dist_perimeter_corners_OFT_in 90004	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:5	CSNA03	open field test	(none)	distance traveled in perimeter and corners, 60 min test (OFT), CC [cm] dist_perimeter_corners_OFT_cc 90005	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:6	CSNA03	open field test	(none)	distance traveled in perimeter and corners, 60 min test (OFT), DO [cm] dist_perimeter_corners_OFT_do 90006	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:7	CSNA03	open field test	(none)	distance traveled in perimeter, 60 min test (OFT), founders [cm] dist_perimeter_OFT_in 90007	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:8	CSNA03	open field test	(none)	distance traveled in perimeter, 60 min test (OFT), CC [cm] dist_perimeter_OFT_cc 90008	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:9	CSNA03	open field test	(none)	distance traveled in perimeter, 60 min test (OFT), DO [cm] dist_perimeter_OFT_do 90009	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:10	CSNA03	open field test	(none)	distance traveled in corners, 60 min test (OFT), founders [cm] dist_corners_OFT_in 90010	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:11	CSNA03	open field test	(none)	distance traveled in corners, 60 min test (OFT), CC [cm] dist_corners_OFT_cc 90011	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:12	CSNA03	open field test	(none)	distance traveled in corners, 60 min test (OFT), DO [cm] dist_corners_OFT_do 90012	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:13	CSNA03	open field test	(none)	percentage of total distance traveled in center, 60 min test (OFT), founders [%] pct_dist_center_OFT_in 90013	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:14	CSNA03	open field test	(none)	percentage of total distance traveled in center, 60 min test (OFT), CC [%] pct_dist_center_OFT_cc 90014	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:15	CSNA03	open field test	(none)	percentage of total distance traveled in center, 60 min test (OFT), DO [%] pct_dist_center_OFT_do 90015	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:16	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), founders dist_slope_OFT_in 90016	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:17	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), CC dist_slope_OFT_cc 90017	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:18	CSNA03	open field test	(none)	distance traveled slope, 60 min test (OFT), DO dist_slope_OFT_do 90018	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:19	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), founders [cm] amb_dist_OFT_in 90019 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:31	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:43	CSNA03	open field test	(none)	distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:55	CSNA03	open field test	(none)	habituation ratio (first:last intervals), 60 min test (OFT), founders [ratio] habituation_OFT_in 90055	inbred w/CC8	10	both	4-14wks	N=35	2018

CSNA03:56	CSNA03	open field test	(none)	habituation ratio (first:last intervals), 60 min test (OFT), CC [ratio] habituation_OFT_cc 90056	CC w/par	59	both	4-19wks	N=15	2018

CSNA03:100	CSNA03	open field test	(none)	time in perimeter and corners, 60 min test (OFT), founders [s] time_perimeter_corners_OFT_in 90100	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:101	CSNA03	open field test	(none)	time in perimeter and corners, 60 min test (OFT), CC [s] time_perimeter_corners_OFT_cc 90101	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:102	CSNA03	open field test	(none)	time in perimeter and corners, 60 min test (OFT), DO [s] time_perimeter_corners_OFT_do 90102	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:103	CSNA03	open field test	(none)	time in perimeter, 60 min test (OFT), founders [s] time_perimeter_OFT_in 90103	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:104	CSNA03	open field test	(none)	time in perimeter, 60 min test (OFT), CC [s] time_perimeter_OFT_cc 90104	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:105	CSNA03	open field test	(none)	time in perimeter, 60 min test (OFT), DO [s] time_perimeter_OFT_do 90105	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:106	CSNA03	open field test	(none)	time in corners, 60 min test (OFT), founders [s] time_corner_OFT_in 90106	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:107	CSNA03	open field test	(none)	time in corners, 60 min test (OFT), CC [s] time_corner_OFT_cc 90107	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:108	CSNA03	open field test	(none)	time in corners, 60 min test (OFT), DO [s] time_corner_OFT_do 90108	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:109	CSNA03	open field test	(none)	percentage of total time spent in center, 60 min test (OFT), founders [%] pct_center_time_OFT_in 90109	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:110	CSNA03	open field test	(none)	percentage of total time spent in center, 60 min test (OFT), CC [%] pct_center_time_OFT_cc 90110	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:111	CSNA03	open field test	(none)	percentage of total time spent in center, 60 min test (OFT), DO [%] pct_center_time_OFT_do 90111	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:112	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter and corners, 60 min test (OFT), founders [%] pct_dist_perimeter_corners_OFT_in 90112	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:113	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC [%] pct_dist_perimeter_corners_OFT_cc 90113	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:114	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter and corners, 60 min test (OFT), DO [%] pct_dist_perimeter_corners_OFT_do 90114	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:115	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter, 60 min test (OFT), founders [%] pct_dist_perimeter_OFT_in 90115	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:116	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter, 60 min test (OFT), CC [%] pct_dist_perimeter_OFT_cc 90116	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:117	CSNA03	open field test	(none)	percentage of total distance traveled in perimeter, 60 min test (OFT), DO [%] pct_dist_perimeter_OFT_do 90117	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:118	CSNA03	open field test	(none)	percentage of total time spent in perimeter and corners, 60 min test (OFT), founders [%] pct_time_perimeter_corner_OFT_in 90118	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:119	CSNA03	open field test	(none)	percentage of total time spent in perimeter and corners, 60 min test (OFT), CC [%] pct_time_perimeter_corner_OFT_cc 90119	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:120	CSNA03	open field test	(none)	percentage of total time spent in perimeter and corners, 60 min test (OFT), DO [%] pct_time_perimeter_corner_OFT_do 90120	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:121	CSNA03	open field test	(none)	percentage of total time spent in perimeter, 60 min test (OFT), founders [%] pct_time_perimeter_OFT_in 90121	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:122	CSNA03	open field test	(none)	percentage of total time spent in perimeter, 60 min test (OFT), CC [%] pct_time_perimeter_OFT_cc 90122	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:123	CSNA03	open field test	(none)	percentage of total time spent in perimeter, 60 min test (OFT), DO [%] pct_time_perimeter_OFT_do 90123	DO population w/par	9	both	4-25wks	N=202	2018

CSNA03:124	CSNA03	open field test	(none)	time in center, 60 min test (OFT), founders [s] center_time_OFT_in 90124	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:125	CSNA03	open field test	(none)	time in center, 60 min test (OFT), CC [s] center_time_OFT_cc 90125	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:127	CSNA03	open field test	(none)	distance traveled in center, 60 min test (OFT), founders [cm] center_dist_OFT_in 90127	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:128	CSNA03	open field test	(none)	distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:130	CSNA03	light-dark box	(none)	total distance traveled, 20 min test (LD box), founders [cm] dist_LD_in 90130	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:131	CSNA03	light-dark box	(none)	total distance traveled, 20 min test (LD box), CC [cm] dist_LD_cc 90131	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:132	CSNA03	light-dark box	(none)	total distance traveled, 20 min test (LD box), DO [cm] dist_LD_do 90132	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:133	CSNA03	light-dark box	(none)	distance traveled in light, 20 min test (LD box), founders [cm] dist_light_LD_in 90133	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:134	CSNA03	light-dark box	(none)	distance traveled in light, 20 min test (LD box), CC [cm] dist_light_LD_cc 90134	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:135	CSNA03	light-dark box	(none)	distance traveled in light, 20 min test (LD box), DO [cm] dist_light_LD_do 90135	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:136	CSNA03	light-dark box	(none)	distance traveled in dark, 20 min test (LD box), founders [cm] dist_dark_LD_in 90136	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:137	CSNA03	light-dark box	(none)	distance traveled in dark, 20 min test (LD box), CC [cm] dist_dark_LD_cc 90137	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:138	CSNA03	light-dark box	(none)	distance traveled in dark, 20 min test (LD box), DO [cm] dist_dark_LD_do 90138	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:139	CSNA03	light-dark box	(none)	percentage of total distance traveled in light, 20 min test (LD box), founders [%] pct_dist_light_LD_in 90139	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:140	CSNA03	light-dark box	(none)	percentage of total distance traveled in light, 20 min test (LD box), CC [%] pct_dist_light_LD_cc 90140	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:141	CSNA03	light-dark box	(none)	percentage of total distance traveled in light, 20 min test (LD box), DO [%] pct_dist_light_LD_do 90141	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:142	CSNA03	light-dark box	(none)	total ambulatory time, 20 min test (LD box), founders [s] amb_time_tot_LD_in 90142	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:143	CSNA03	light-dark box	(none)	total ambulatory time, 20 min test (LD box), CC [s] amb_time_tot_LD_cc 90143	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:144	CSNA03	light-dark box	(none)	total ambulatory time, 20 min test (LD box), DO [s] amb_time_tot_LD_do 90144	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:145	CSNA03	light-dark box	(none)	ambulatory time in light, 20 min test (LD box), founders [s] amb_time_light_LD_in 90145	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:146	CSNA03	light-dark box	(none)	ambulatory time in light, 20 min test (LD box), CC [s] amb_time_light_LD_cc 90146	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:147	CSNA03	light-dark box	(none)	ambulatory time in light, 20 min test (LD box), DO [s] amb_time_light_LD_do 90147	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:148	CSNA03	light-dark box	(none)	ambulatory time in dark, 20 min test (LD box), founders [s] amb_time_dark_LD_in 90148	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:149	CSNA03	light-dark box	(none)	ambulatory time in dark, 20 min test (LD box), CC [s] amb_time_dark_LD_cc 90149	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:150	CSNA03	light-dark box	(none)	ambulatory time in dark, 20 min test (LD box), DO [s] amb_time_dark_LD_do 90150	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:151	CSNA03	light-dark box	(none)	percentage of time spent ambulatory in light, 20 min test (LD box), founders [%] pct_amb_time_light_LD_in 90151	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:152	CSNA03	light-dark box	(none)	percentage of time spent ambulatory in light, 20 min test (LD box), CC [%] pct_amb_time_light_LD_cc 90152	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:153	CSNA03	light-dark box	(none)	percentage of time spent ambulatory in light, 20 min test (LD box), DO [%] pct_amb_time_light_LD_do 90153	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:163	CSNA03	light-dark box	(none)	percentage of time resting in light, 20 min test (LD box), founders [%] pct_rest_time_light_LD_in 90163	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:164	CSNA03	light-dark box	(none)	percentage of time resting in light, 20 min test (LD box), CC [%] pct_rest_time_light_LD_cc 90164	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:165	CSNA03	light-dark box	(none)	percentage of time resting in light, 20 min test (LD box), DO [%] pct_rest_time_light_LD_do 90165	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:202	CSNA03	light-dark box	(none)	total time, 20 min test (LD box), founders [s] time_tot_LD_in 90202	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:203	CSNA03	light-dark box	(none)	total time, 20 min test (LD box), CC [s] time_tot_LD_cc 90203	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:204	CSNA03	light-dark box	(none)	total time, 20 min test (LD box), DO [s] time_tot_LD_do 90204	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:205	CSNA03	light-dark box	(none)	time in light, 20 min test (LD box), founders [s] time_light_LD_in 90205	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:206	CSNA03	light-dark box	(none)	time in light, 20 min test (LD box), CC [s] time_light_LD_cc 90206	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:208	CSNA03	light-dark box	(none)	time in dark, 20 min test (LD box), founders [s] time_dark_LD_in 90208	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:209	CSNA03	light-dark box	(none)	time in dark, 20 min test (LD box), CC [s] time_dark_LD_cc 90209	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:210	CSNA03	light-dark box	(none)	time in dark, 20 min test (LD box), DO [s] time_dark_LD_do 90210	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:211	CSNA03	light-dark box	(none)	percentage of time in light, 20 min test (LD box), founders [%] pct_time_light_LD_in 90211	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:212	CSNA03	light-dark box	(none)	percentage of time in light, 20 min test (LD box), CC [%] pct_time_light_LD_cc 90212	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:213	CSNA03	light-dark box	(none)	percentage of time in light, 20 min test (LD box), DO [%] pct_time_light_LD_do 90213	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:214	CSNA03	light-dark box	(none)	total ambulatory counts, 20 min test (LD box), founders [n] amb_counts_tot_LD_in 90214	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:215	CSNA03	light-dark box	(none)	total ambulatory counts, 20 min test (LD box), CC [n] amb_counts_tot_LD_cc 90215	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:216	CSNA03	light-dark box	(none)	total ambulatory counts, 20 min test (LD box), DO [n] amb_counts_tot_LD_do 90216	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:217	CSNA03	light-dark box	(none)	ambulatory counts in light, 20 min test (LD box), founders [n] amb_counts_light_LD_in 90217	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:218	CSNA03	light-dark box	(none)	ambulatory counts in light, 20 min test (LD box), CC [n] amb_counts_light_LD_cc 90218	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:219	CSNA03	light-dark box	(none)	ambulatory counts in light, 20 min test (LD box), DO [n] amb_counts_light_LD_do 90219	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:220	CSNA03	light-dark box	(none)	ambulatory counts in dark, 20 min test (LD box), founders [n] amb_counts_dark_LD_in 90220	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:221	CSNA03	light-dark box	(none)	ambulatory counts in dark, 20 min test (LD box), CC [n] amb_counts_dark_LD_cc 90221	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:222	CSNA03	light-dark box	(none)	ambulatory counts in dark, 20 min test (LD box), DO [n] amb_counts_dark_LD_do 90222	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:223	CSNA03	light-dark box	(none)	percentage of ambulatory counts in light, 20 min test (LD box), founders [%] pct_amb_counts_light_LD_in 90223	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:224	CSNA03	light-dark box	(none)	percentage of ambulatory counts in light, 20 min test (LD box), CC [%] pct_amb_counts_light_LD_cc 90224	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:225	CSNA03	light-dark box	(none)	percentage of ambulatory counts in light, 20 min test (LD box), DO [%] pct_amb_counts_light_LD_do 90225	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:262	CSNA03	light-dark box	(none)	total number of light-dark transitions, 20 min test (LD box), founders [n] light_dark_transitions_LD_in 90262	inbred w/CC8	10	both	4-14wks	N=43	2018

CSNA03:263	CSNA03	light-dark box	(none)	total number of light-dark transitions, 20 min test (LD box), CC [n] light_dark_transitions_LD_cc 90263	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:264	CSNA03	light-dark box	(none)	total number of light-dark transitions, 20 min test (LD box), DO [n] light_dark_transitions_LD_do 90264	DO population w/par	9	both	4-25wks	N=205	2018

CSNA03:265	CSNA03	hole board test	(none)	total number of entries (hole board), founders [n] entries_total_HB_in 90265	inbred w/CC8	10	both	4-13wks	N=40	2018

CSNA03:266	CSNA03	hole board test	(none)	total number of entries (hole board), CC [n] entries_total_HB_cc 90266	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:267	CSNA03	hole board test	(none)	total number of entries (hole board), DO [n] entries_total_HB_do 90267	DO population w/par	9	both	4-25wks	N=193	2018

CSNA03:268	CSNA03	hole board test	(none)	number of novel entries (hole board), founders [n] entries_novel_HB_in 90268	inbred w/CC8	10	both	4-13wks	N=40	2018

CSNA03:269	CSNA03	hole board test	(none)	number of novel entries (hole board), CC [n] entries_novel_HB_cc 90269	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:270	CSNA03	hole board test	(none)	number of novel entries (hole board), DO [n] entries_novel_HB_do 90270	DO population w/par	9	both	4-25wks	N=193	2018

CSNA03:271	CSNA03	hole board test	(none)	number of repeat entries (hole board), founders [n] entries_repeat_HB_in 90271	inbred w/CC8	10	both	4-13wks	N=40	2018

CSNA03:272	CSNA03	hole board test	(none)	number of repeat entries (hole board), CC [n] entries_repeat_HB_cc 90272	CC w/par	59	both	4-19wks	N=18	2018

CSNA03:273	CSNA03	hole board test	(none)	number of repeat entries (hole board), DO [n] entries_repeat_HB_do 90273	DO population w/par	9	both	4-25wks	N=193	2018

CSNA03:286	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, excluding center gray zone (novelty preference), founders [%] time_wo_gray_in 90286	inbred w/CC8	10	both	12wks	N=40	2018

CSNA03:287	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, excluding center gray zone (novelty preference), CC [%] time_wo_gray_cc 90287	CC w/par	59	both	6-14wks	N=17	2018

CSNA03:288	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, excluding center gray zone (novelty preference), DO [%] time_wo_gray_do 90288	DO population w/par	9	both	8-25wks	N=190	2018

CSNA03:289	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, including center gray zone (novelty preference), founders [%] time_w_gray_in 90289	inbred w/CC8	10	both	12wks	N=40	2018

CSNA03:290	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, including center gray zone (novelty preference), CC [%] time_w_gray_cc 90290	CC w/par	59	both	6-14wks	N=17	2018

CSNA03:291	CSNA03	conditioned place preference test	(none)	percentage of time spent in novel zone, including center gray zone (novelty preference), DO [%] time_w_gray_do 90291	DO population w/par	9	both	8-25wks	N=190	2018

CSNA03:304	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, founders [cm] dist_d3_d2_cont_in 90304	inbred w/CC8	9	both	8-14wks	N=6	2018

CSNA03:305	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, CC [cm] dist_d3_d2_cont_cc 90305	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:306	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, DO [cm] dist_d3_d2_cont_do 90306	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:307	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d3_d2_cocaine_in 90307	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:308	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d3_d2_cocaine_cc 90308	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:309	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d3_d2_cocaine_do 90309	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:310	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, founders [cm] dist_d5_d3_cont_in 90310	inbred w/CC8	9	both	8-14wks	N=6	2018

CSNA03:311	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, CC [cm] dist_d5_d3_cont_cc 90311	CC w/par	58	both	8-21wks	N=3	2018

CSNA03:312	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO [cm] dist_d5_d3_cont_do 90312	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:313	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, founders [cm] dist_d5_d3_cocaine_in 90313	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:314	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, CC [cm] dist_d5_d3_cocaine_cc 90314	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:315	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO [cm] dist_d5_d3_cocaine_do 90315	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:316	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, founders [cm] dist_d12_d2_cont_in 90316	inbred w/CC8	9	both	8-14wks	N=6	2018

CSNA03:317	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, CC [cm] dist_d12_d2_cont_cc 90317	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:318	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, DO [cm] dist_d12_d2_cont_do 90318	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:319	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d12_d2_cocaine_in 90319	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:320	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d12_d2_cocaine_cc 90320	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:321	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:322	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, founders [cm] dist_d19_d11_cont_in 90322	inbred w/CC8	9	both	8-14wks	N=7	2018

CSNA03:323	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, CC [cm] dist_d19_d11_cont_cc 90323	CC w/par	58	both	8-21wks	N=3	2018

CSNA03:324	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, DO [cm] dist_d19_d11_cont_do 90324	DO population w/par	9	both	8-21wks	N=22	2018

CSNA03:325	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, founders [cm] dist_d19_d11_cocaine_in 90325	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:326	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, CC [cm] dist_d19_d11_cocaine_cc 90326	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:327	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO [cm] dist_d19_d11_cocaine_do 90327	DO population w/par	9	both	8-21wks	N=23	2018

CSNA03:328	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, founders dist_d3_d11_auc_cont_in 90437	inbred w/CC8	9	both	8-14wks	N=6	2018

CSNA03:329	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, CC dist_d3_d11_auc_cont_cc 90438	CC w/par	58	both	8-21wks	N=3	2018

CSNA03:330	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, DO dist_d3_d11_auc_cont_do 90439	DO population w/par	9	both	8-21wks	N=21	2018

CSNA03:331	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, founders dist_d3_d11_auc_cocaine_in 90440	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:332	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, CC dist_d3_d11_auc_cocaine_cc 90441	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:333	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, DO dist_d3_d11_auc_cocaine_do 90442	DO population w/par	9	both	8-21wks	N=21	2018

CSNA03:334	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, founders [cm] dist_f30_cont_in 90328 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	9	both	8-14wks	N=7	2018

CSNA03:343	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:352	CSNA03	open field test	(none)	distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:361	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:370	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:379	CSNA03	open field test	cocaine	distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:388	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, founders [cm] dist_l60_cont_in 90382 day: 1 2 3 5 7 9 11 12 19	inbred w/CC8	9	both	8-14wks	N=7	2018

CSNA03:397	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:406	CSNA03	open field test	(none)	distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19	DO population w/par	9	both	8-21wks	N=26	2018

CSNA03:415	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders [cm] dist_l60_cocaine_in 90385 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	inbred w/CC8	10	both	8-14wks	N=6	2018

CSNA03:424	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	CC w/par	58	both	8-21wks	N=4	2018

CSNA03:433	CSNA03	open field test	cocaine	distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19	DO population w/par	9	both	8-21wks	N=27	2018

CSNA03:449	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188	inbred w/CC8	7	both	4-25wks	N=10	2018

CSNA03:450	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390	CC w/par	53	both	4-25wks	N=4	2018

CSNA03:451	CSNA03	operant conditioning chamber	cocaine	number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261	DO population w/par	8	both	4-25wks	N=48	2018

CSNA03:452	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	inbred w/CC8	8	both	4-25wks	N=14	2018

CSNA03:461	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	CC w/par	57	both	4-25wks	N=6	2018

CSNA03:470	CSNA03	operant conditioning chamber	cocaine	dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)	DO population w/par	9	both	4-25wks	N=73	2018

CSNA03:479	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:488	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:497	CSNA03	operant conditioning chamber	cocaine	extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:506	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:515	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:524	CSNA03	operant conditioning chamber	cocaine	extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9	DO population w/par	8	both	4-25wks	N=39	2018

CSNA03:533	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:535	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:537	CSNA03	operant conditioning chamber	cocaine	reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:540	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:542	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:544	CSNA03	operant conditioning chamber	cocaine	reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:547	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2	inbred w/CC8	7	both	4-25wks	N=7	2018

CSNA03:549	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2	CC w/par	54	both	4-25wks	N=3	2018

CSNA03:551	CSNA03	operant conditioning chamber	cocaine	reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3	DO population w/par	8	both	4-25wks	N=42	2018

CSNA03:554	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:556	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:558	CSNA03	operant conditioning chamber	(none)	number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:560	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:562	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:564	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:566	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850	inbred w/CC8	8	both		N=7	2021

CSNA03:567	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851	CC w/par	52	both		N=3	2021

CSNA03:568	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853	DO population w/par	9	both		N=28	2021

CSNA03:569	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:571	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:573	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:575	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:577	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:579	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:581	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:583	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:585	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:587	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:589	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:591	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:593	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:595	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:597	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:605	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:607	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:609	CSNA03	operant conditioning chamber	(none)	mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:617	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:619	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:621	CSNA03	operant conditioning chamber	(none)	latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:623	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:625	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:627	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:629	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:631	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:633	CSNA03	operant conditioning chamber	(none)	total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:635	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:637	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:639	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:641	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal	inbred w/CC8	8	both	4-25wks	N=7	2018

CSNA03:643	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal	CC w/par	52	both	4-25wks	N=3	2018

CSNA03:645	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal	DO population w/par	9	both	4-25wks	N=28	2018

CSNA03:647	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:649	CSNA03	operant conditioning chamber	(none)	total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:651	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852	inbred w/CC8	8	both		N=5	2021

CSNA03:652	CSNA03	operant conditioning chamber	(none)	reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854	CC w/par	18	both		N=4	2021

CSNA03:653	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:655	CSNA03	operant conditioning chamber	(none)	total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:657	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:659	CSNA03	operant conditioning chamber	(none)	total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:661	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:663	CSNA03	operant conditioning chamber	(none)	percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:665	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:667	CSNA03	operant conditioning chamber	(none)	percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:669	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:671	CSNA03	operant conditioning chamber	(none)	total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:673	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal	inbred w/CC8	8	both		N=6	2021

CSNA03:675	CSNA03	operant conditioning chamber	(none)	mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:677	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:679	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:681	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal	inbred w/CC8	8	both		N=5	2021

CSNA03:683	CSNA03	operant conditioning chamber	(none)	mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal	CC w/par	18	both		N=4	2021

CSNA03:685	CSNA03	in vitro assay	(none)	peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders [h] period_in 112539	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:686	CSNA03	in vitro assay	(none)	peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC [h] period_cc 112544	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:688	CSNA03	in vitro assay	(none)	specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders [n] phase_in 112540	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:689	CSNA03	in vitro assay	(none)	specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC [n] phase_cc 112545	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:691	CSNA03	in vitro assay	(none)	peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders [n/s] amplitude_in 112541	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03:692	CSNA03	in vitro assay	(none)	peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546	CC w/par	40	both	8-12wks	N=4	2020

CSNA03:694	CSNA03	in vitro assay	(none)	number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders [days] damping_in 112542	inbred w/CC8	8	both	8-12wks	N=9	2020

CSNA03

open field test

(none)

total distance traveled, 60 min test (OFT), founders [cm] dist_OFT_in 90001

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

total distance traveled, 60 min test (OFT), CC [cm] dist_OFT_cc 90002

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), founders [cm] dist_perimeter_corners_OFT_in 90004

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), CC [cm] dist_perimeter_corners_OFT_cc 90005

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter and corners, 60 min test (OFT), DO [cm] dist_perimeter_corners_OFT_do 90006

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), founders [cm] dist_perimeter_OFT_in 90007

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), CC [cm] dist_perimeter_OFT_cc 90008

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in perimeter, 60 min test (OFT), DO [cm] dist_perimeter_OFT_do 90009

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), founders [cm] dist_corners_OFT_in 90010

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), CC [cm] dist_corners_OFT_cc 90011

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in corners, 60 min test (OFT), DO [cm] dist_corners_OFT_do 90012

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), founders [%] pct_dist_center_OFT_in 90013

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), CC [%] pct_dist_center_OFT_cc 90014

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in center, 60 min test (OFT), DO [%] pct_dist_center_OFT_do 90015

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), founders dist_slope_OFT_in 90016

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), CC dist_slope_OFT_cc 90017

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled slope, 60 min test (OFT), DO dist_slope_OFT_do 90018

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), founders [cm] amb_dist_OFT_in 90019 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), CC [cm] amb_dist_OFT_cc 90020 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in successive 5 min intervals, 60 min test (OFT), DO [cm] amb_dist_OFT_do 90021 min: 0-5 5-10 10-15 15-20 20-25 25-30 30-35 35-40 40-45 45-50 50-55 55-60

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

habituation ratio (first:last intervals), 60 min test (OFT), founders [ratio] habituation_OFT_in 90055

inbred w/CC8

10

both

4-14wks

N=35

2018

CSNA03

open field test

(none)

habituation ratio (first:last intervals), 60 min test (OFT), CC [ratio] habituation_OFT_cc 90056

CC w/par

59

both

4-19wks

N=15

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), founders [s] time_perimeter_corners_OFT_in 90100

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), CC [s] time_perimeter_corners_OFT_cc 90101

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in perimeter and corners, 60 min test (OFT), DO [s] time_perimeter_corners_OFT_do 90102

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), founders [s] time_perimeter_OFT_in 90103

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), CC [s] time_perimeter_OFT_cc 90104

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in perimeter, 60 min test (OFT), DO [s] time_perimeter_OFT_do 90105

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), founders [s] time_corner_OFT_in 90106

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), CC [s] time_corner_OFT_cc 90107

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

time in corners, 60 min test (OFT), DO [s] time_corner_OFT_do 90108

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), founders [%] pct_center_time_OFT_in 90109

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), CC [%] pct_center_time_OFT_cc 90110

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in center, 60 min test (OFT), DO [%] pct_center_time_OFT_do 90111

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), founders [%] pct_dist_perimeter_corners_OFT_in 90112

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), CC [%] pct_dist_perimeter_corners_OFT_cc 90113

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter and corners, 60 min test (OFT), DO [%] pct_dist_perimeter_corners_OFT_do 90114

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), founders [%] pct_dist_perimeter_OFT_in 90115

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), CC [%] pct_dist_perimeter_OFT_cc 90116

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total distance traveled in perimeter, 60 min test (OFT), DO [%] pct_dist_perimeter_OFT_do 90117

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), founders [%] pct_time_perimeter_corner_OFT_in 90118

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), CC [%] pct_time_perimeter_corner_OFT_cc 90119

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter and corners, 60 min test (OFT), DO [%] pct_time_perimeter_corner_OFT_do 90120

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), founders [%] pct_time_perimeter_OFT_in 90121

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), CC [%] pct_time_perimeter_OFT_cc 90122

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

percentage of total time spent in perimeter, 60 min test (OFT), DO [%] pct_time_perimeter_OFT_do 90123

DO population w/par

9

both

4-25wks

N=202

2018

CSNA03

open field test

(none)

time in center, 60 min test (OFT), founders [s] center_time_OFT_in 90124

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

time in center, 60 min test (OFT), CC [s] center_time_OFT_cc 90125

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

open field test

(none)

distance traveled in center, 60 min test (OFT), founders [cm] center_dist_OFT_in 90127

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

open field test

(none)

distance traveled in center, 60 min test (OFT), CC [cm] center_dist_OFT_cc 90128

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), founders [cm] dist_LD_in 90130

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), CC [cm] dist_LD_cc 90131

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total distance traveled, 20 min test (LD box), DO [cm] dist_LD_do 90132

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), founders [cm] dist_light_LD_in 90133

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), CC [cm] dist_light_LD_cc 90134

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

distance traveled in light, 20 min test (LD box), DO [cm] dist_light_LD_do 90135

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), founders [cm] dist_dark_LD_in 90136

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), CC [cm] dist_dark_LD_cc 90137

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

distance traveled in dark, 20 min test (LD box), DO [cm] dist_dark_LD_do 90138

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), founders [%] pct_dist_light_LD_in 90139

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), CC [%] pct_dist_light_LD_cc 90140

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of total distance traveled in light, 20 min test (LD box), DO [%] pct_dist_light_LD_do 90141

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), founders [s] amb_time_tot_LD_in 90142

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), CC [s] amb_time_tot_LD_cc 90143

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total ambulatory time, 20 min test (LD box), DO [s] amb_time_tot_LD_do 90144

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), founders [s] amb_time_light_LD_in 90145

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), CC [s] amb_time_light_LD_cc 90146

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory time in light, 20 min test (LD box), DO [s] amb_time_light_LD_do 90147

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), founders [s] amb_time_dark_LD_in 90148

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), CC [s] amb_time_dark_LD_cc 90149

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory time in dark, 20 min test (LD box), DO [s] amb_time_dark_LD_do 90150

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), founders [%] pct_amb_time_light_LD_in 90151

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), CC [%] pct_amb_time_light_LD_cc 90152

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time spent ambulatory in light, 20 min test (LD box), DO [%] pct_amb_time_light_LD_do 90153

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), founders [%] pct_rest_time_light_LD_in 90163

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), CC [%] pct_rest_time_light_LD_cc 90164

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time resting in light, 20 min test (LD box), DO [%] pct_rest_time_light_LD_do 90165

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), founders [s] time_tot_LD_in 90202

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), CC [s] time_tot_LD_cc 90203

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total time, 20 min test (LD box), DO [s] time_tot_LD_do 90204

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

time in light, 20 min test (LD box), founders [s] time_light_LD_in 90205

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

time in light, 20 min test (LD box), CC [s] time_light_LD_cc 90206

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), founders [s] time_dark_LD_in 90208

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), CC [s] time_dark_LD_cc 90209

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

time in dark, 20 min test (LD box), DO [s] time_dark_LD_do 90210

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), founders [%] pct_time_light_LD_in 90211

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), CC [%] pct_time_light_LD_cc 90212

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of time in light, 20 min test (LD box), DO [%] pct_time_light_LD_do 90213

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), founders [n] amb_counts_tot_LD_in 90214

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), CC [n] amb_counts_tot_LD_cc 90215

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total ambulatory counts, 20 min test (LD box), DO [n] amb_counts_tot_LD_do 90216

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), founders [n] amb_counts_light_LD_in 90217

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), CC [n] amb_counts_light_LD_cc 90218

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory counts in light, 20 min test (LD box), DO [n] amb_counts_light_LD_do 90219

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), founders [n] amb_counts_dark_LD_in 90220

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), CC [n] amb_counts_dark_LD_cc 90221

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

ambulatory counts in dark, 20 min test (LD box), DO [n] amb_counts_dark_LD_do 90222

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), founders [%] pct_amb_counts_light_LD_in 90223

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), CC [%] pct_amb_counts_light_LD_cc 90224

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

percentage of ambulatory counts in light, 20 min test (LD box), DO [%] pct_amb_counts_light_LD_do 90225

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), founders [n] light_dark_transitions_LD_in 90262

inbred w/CC8

10

both

4-14wks

N=43

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), CC [n] light_dark_transitions_LD_cc 90263

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

light-dark box

(none)

total number of light-dark transitions, 20 min test (LD box), DO [n] light_dark_transitions_LD_do 90264

DO population w/par

9

both

4-25wks

N=205

2018

CSNA03

hole board test

(none)

total number of entries (hole board), founders [n] entries_total_HB_in 90265

inbred w/CC8

10

both

4-13wks

N=40

2018

CSNA03

hole board test

(none)

total number of entries (hole board), CC [n] entries_total_HB_cc 90266

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

total number of entries (hole board), DO [n] entries_total_HB_do 90267

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), founders [n] entries_novel_HB_in 90268

inbred w/CC8

10

both

4-13wks

N=40

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), CC [n] entries_novel_HB_cc 90269

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

number of novel entries (hole board), DO [n] entries_novel_HB_do 90270

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), founders [n] entries_repeat_HB_in 90271

inbred w/CC8

10

both

4-13wks

N=40

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), CC [n] entries_repeat_HB_cc 90272

CC w/par

59

both

4-19wks

N=18

2018

CSNA03

hole board test

(none)

number of repeat entries (hole board), DO [n] entries_repeat_HB_do 90273

DO population w/par

9

both

4-25wks

N=193

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), founders [%] time_wo_gray_in 90286

inbred w/CC8

10

both

12wks

N=40

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), CC [%] time_wo_gray_cc 90287

CC w/par

59

both

6-14wks

N=17

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, excluding center gray zone (novelty preference), DO [%] time_wo_gray_do 90288

DO population w/par

9

both

8-25wks

N=190

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), founders [%] time_w_gray_in 90289

inbred w/CC8

10

both

12wks

N=40

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), CC [%] time_w_gray_cc 90290

CC w/par

59

both

6-14wks

N=17

2018

CSNA03

conditioned place preference test

(none)

percentage of time spent in novel zone, including center gray zone (novelty preference), DO [%] time_w_gray_do 90291

DO population w/par

9

both

8-25wks

N=190

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, founders [cm] dist_d3_d2_cont_in 90304

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, CC [cm] dist_d3_d2_cont_cc 90305

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 minus Day 2, saline control, DO [cm] dist_d3_d2_cont_do 90306

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d3_d2_cocaine_in 90307

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d3_d2_cocaine_cc 90308

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d3_d2_cocaine_do 90309

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, founders [cm] dist_d5_d3_cont_in 90310

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, CC [cm] dist_d5_d3_cont_cc 90311

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 5 minus Day 3, saline control, DO [cm] dist_d5_d3_cont_do 90312

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, founders [cm] dist_d5_d3_cocaine_in 90313

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, CC [cm] dist_d5_d3_cocaine_cc 90314

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 5 (cocaine) minus Day 3 (cocaine), cocaine sensitization, DO [cm] dist_d5_d3_cocaine_do 90315

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, founders [cm] dist_d12_d2_cont_in 90316

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, CC [cm] dist_d12_d2_cont_cc 90317

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 12 minus Day 2, saline control, DO [cm] dist_d12_d2_cont_do 90318

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, founders [cm] dist_d12_d2_cocaine_in 90319

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, CC [cm] dist_d12_d2_cocaine_cc 90320

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 12 (saline) minus Day 2 (saline), cocaine sensitization, DO [cm] dist_d12_d2_cocaine_do 90321

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, founders [cm] dist_d19_d11_cont_in 90322

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, CC [cm] dist_d19_d11_cont_cc 90323

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 19 minus Day 11, saline control, DO [cm] dist_d19_d11_cont_do 90324

DO population w/par

9

both

8-21wks

N=22

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, founders [cm] dist_d19_d11_cocaine_in 90325

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, CC [cm] dist_d19_d11_cocaine_cc 90326

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 19 (cocaine) minus Day 11 (cocaine), cocaine sensitization, DO [cm] dist_d19_d11_cocaine_do 90327

DO population w/par

9

both

8-21wks

N=23

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, founders dist_d3_d11_auc_cont_in 90437

inbred w/CC8

9

both

8-14wks

N=6

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, CC dist_d3_d11_auc_cont_cc 90438

CC w/par

58

both

8-21wks

N=3

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), Day 3 to Day 11 AUC, saline control, DO dist_d3_d11_auc_cont_do 90439

DO population w/par

9

both

8-21wks

N=21

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, founders dist_d3_d11_auc_cocaine_in 90440

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, CC dist_d3_d11_auc_cocaine_cc 90441

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), Day 3 (cocaine) to Day 11 (cocaine) AUC, cocaine sensitization, DO dist_d3_d11_auc_cocaine_do 90442

DO population w/par

9

both

8-21wks

N=21

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, founders [cm] dist_f30_cont_in 90328 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, CC [cm] dist_f30_cont_cc 90329 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, first 30 min (pre-injection), on successive days, saline group, DO [cm] dist_f30_cont_do 90330 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, founders [cm] dist_f30_cocaine_in 90331 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, CC [cm] dist_f30_cocaine_cc 90332 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, first 30 min (pre-injection), on successive days, cocaine group, DO [cm] dist_f30_cocaine_do 90333 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, founders [cm] dist_l60_cont_in 90382 day: 1 2 3 5 7 9 11 12 19

inbred w/CC8

9

both

8-14wks

N=7

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, CC [cm] dist_l60_cont_cc 90383 day: 1 2 3 5 7 9 11 12 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

(none)

distance traveled, last 60 min (post-injection), on successive days, saline control, DO [cm] dist_l60_cont_do 90384 day: 1 2 3 5 7 9 11 12 19

DO population w/par

9

both

8-21wks

N=26

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, founders [cm] dist_l60_cocaine_in 90385 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

inbred w/CC8

10

both

8-14wks

N=6

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, CC [cm] dist_l60_cocaine_cc 90386 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

CC w/par

58

both

8-21wks

N=4

2018

CSNA03

open field test

cocaine

distance traveled, last 60 min (post-injection), on successive days, cocaine sensitization, DO [cm] dist_l60_cocaine_do 90387 day: 1 (saline) 2 (saline) 3 5 7 9 11 12 (saline) 19

DO population w/par

9

both

8-21wks

N=27

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), founders [n] acquisition_in 110188

inbred w/CC8

7

both

4-25wks

N=10

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), CC [n] acquisition_cc 110390

CC w/par

53

both

4-25wks

N=4

2018

CSNA03

operant conditioning chamber

cocaine

number of sessions to acquisition (1.0 mg/kg) (intravenous self administration), DO [n] acquisition_do 110261

DO population w/par

8

both

4-25wks

N=48

2018

CSNA03

operant conditioning chamber

cocaine

dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, founders [n] infusions_in 110189 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

inbred w/CC8

8

both

4-25wks

N=14

2018

CSNA03

operant conditioning chamber

cocaine

dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, CC [n] infusions_cc 110391 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

CC w/par

57

both

4-25wks

N=6

2018

CSNA03

operant conditioning chamber

cocaine

dose response, mean number of infusions (intravenous self administration) on last two stabilized sessions, DO [n] infusions_do 110262 mg/kg: 1.0 1.8 0.56 0.32 0.1 0.18 0.056 0.032 1.0 (2nd)

DO population w/par

9

both

4-25wks

N=73

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), founders [n] extinction_active_in 110198 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), CC [n] extinction_active_cc 110400 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, active lever presses (intravenous self administration), DO [n] extinction_active_do 110271 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), founders [n] extinction_inactive_in 110207 session: 1 2 3 4 5 6 7 8 9

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), CC [n] extinction_inactive_cc 110409 session: 1 2 3 4 5 6 7 8 9

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

extinction, inactive lever presses (intravenous self administration), DO [n] extinction_inactive_do 110280 session: 1 2 3 4 5 6 7 8 9

DO population w/par

8

both

4-25wks

N=39

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), founders [n] reinstatement_active_in 110216 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), CC [n] reinstatement_active_cc 110418 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, active lever presses (intravenous self administration), DO [n] reinstatement_active_do 110289 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), founders [n] reinstatement_inactive_in 110218 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), CC [n] reinstatement_inactive_cc 110420 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, inactive lever presses (intravenous self administration), DO [n] reinstatement_inactive_do 110292 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), founders [n] reinstatement_inf_in 110220 session: 1 2

inbred w/CC8

7

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), CC [n] reinstatement_inf_cc 110422 session: 1 2

CC w/par

54

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

cocaine

reinstatement, number of infusions (intravenous self administration), DO [n] reinstatement_inf_do 110295 session: 1 2 3

DO population w/par

8

both

4-25wks

N=42

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), founders [n] days_criteria_in_JAX 110457 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), CC [n] days_criteria_cc_JAX 110487 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

number of days to meet criteria, (reversal learning assay), DO [n] days_criteria_do_JAX 110517 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_JAX 110459 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_JAX 110489 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), DO [n] trials_do_JAX 110519 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_JAX 113850

inbred w/CC8

8

both

N=7

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_JAX 113851

CC w/par

52

both

N=3

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), DO [n] diff_trials_rev_acq_do_JAX 113853

DO population w/par

9

both

N=28

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_JAX 110461 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_JAX 110491 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), DO [n] correct_do_JAX 110521 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_JAX 110463 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_JAX 110493 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), DO [n] omit_do_JAX 110523 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_JAX 110465 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_JAX 110495 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), DO [%] pct_correct_do_JAX 110525 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_JAX 110467 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_JAX 110497 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), DO [%] pct_omit_do_JAX 110527 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_JAX 110469 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_JAX 110499 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), DO [min] total_time_do_JAX 110529 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_JAX 110473 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_JAX 110503 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean latency across trials between illumination of central hole and initiation of trial (reversal learning assay), DO [centiseconds/n] trial_init_latency_do_JAX 110533 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), founders [centiseconds/n] reward_time_in_JAX 110477 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), CC [centiseconds/n] reward_time_cc_JAX 110507 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

latency to retrieve reward per total correct responses (reversal learning assay), DO [centiseconds/n] reward_time_do_JAX 110537 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_left_in_JAX 110479 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_left_cc_JAX 110509 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in left flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_left_do_JAX 110539 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_resp_right_in_JAX 110481 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_resp_right_cc_JAX 110511 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

total number of anticipatory responses in right flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_resp_right_do_JAX 110541 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_JAX 110483 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_JAX 110513 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_correct_do_JAX 110543 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_JAX 110485 acquisition reversal

inbred w/CC8

8

both

4-25wks

N=7

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_JAX 110515 acquisition reversal

CC w/par

52

both

4-25wks

N=3

2018

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), DO [n] antici_incorrect_do_JAX 110545 acquisition reversal

DO population w/par

9

both

4-25wks

N=28

2018

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), founders [n] trials_in_Binghamton 112873 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of trials (reversal learning assay), CC [n] trials_cc_Binghamton 112891 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), founders [n] diff_trials_rev_acq_in_Binghamton 113852

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

reversal trials minus acquisition trials (reversal learning assay), CC [n] diff_trials_rev_acq_cc_Binghamton 113854

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), founders [n] correct_in_Binghamton 112875 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total number of correct responses (successful response in central nose poke hole with subsequent response in correct flanking hole) (reversal learning assay), CC [n] correct_cc_Binghamton 112893 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), founders [n] omit_in_Binghamton 112877 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

total number of omissions (successful response in central nose poke hole, but no response in flanking hole within 30 s) (reversal learning assay), CC [n] omit_cc_Binghamton 112895 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), founders [%] pct_correct_in_Binghamton 112879 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses that are correct (reversal learning assay), CC [%] pct_correct_cc_Binghamton 112897 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), founders [%] pct_omit_in_Binghamton 112881 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

percentage of responses considered omissions (reversal learning assay), CC [%] pct_omit_cc_Binghamton 112899 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), founders [min] total_time_in_Binghamton 112883 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

total time for all trials (reversal learning assay), CC [min] total_time_cc_Binghamton 112901 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), founders [centiseconds/n] trial_init_latency_in_Binghamton 112885 acquisition reversal

inbred w/CC8

8

both

N=6

2021

CSNA03

operant conditioning chamber

(none)

mean latency (across trials) between illumination of central hole and initiation of trial (reversal learning assay), CC [centiseconds/n] trial_init_latency_cc_Binghamton 112903 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_correct_in_Binghamton 112887 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in correct flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_correct_cc_Binghamton 112905 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), founders [n] antici_incorrect_in_Binghamton 112889 acquisition reversal

inbred w/CC8

8

both

N=5

2021

CSNA03

operant conditioning chamber

(none)

mean number of anticipatory nose pokes made in incorrect flanking hole without prior successful nose poke in central hole (reversal learning assay), CC [n] antici_incorrect_cc_Binghamton 112907 acquisition reversal

CC w/par

18

both

N=4

2021

CSNA03

in vitro assay

(none)

peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, founders [h] period_in 112539

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

peak-to-peak interval, indicating amount of time it takes for one cycle of bioluminescence circadian rhythm, in fibroblast cultures, CC [h] period_cc 112544

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, founders [n] phase_in 112540

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

specific time point when bioluminescence reaches highest circadian rhythm amplitude (cycle number), in fibroblast cultures, CC [n] phase_cc 112545

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, founders [n/s] amplitude_in 112541

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

peak-to-trough, indicating level of synchronization in circadian rhythm (max counts/s), in fibroblast cultures, CC [n/s] amplitude_cc 112546

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, founders [days] damping_in 112542

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

number of days required for circadian rhythm amplitude to decrease to 36% of initial value, in fibroblast cultures, CC [days] damping_cc 112547

CC w/par

40

both

8-12wks

N=4

2020

CSNA03

in vitro assay

(none)

percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, founders [%] goodness_of_fit_in 112543

inbred w/CC8

8

both

8-12wks

N=9

2020

CSNA03

in vitro assay

(none)

percentage of observed rhythms that fit expected sine wave, indicating stability and robustness of circadian rhythm, in fibroblast cultures, CC [%] goodness_of_fit_cc 112548

CC w/par

40

both

8-12wks

N=4

2020

Find data for mouse strain: CC006/TauUncJ

Filter Table Results